Auckland Myopia Clinic
Auckland, 1052, New Zealand
Location status: Recruiting
NCT Number: NCT07535749
The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children.
The study duration will be 6 months, with assessments conducted at baseline, 2 weeks, 3 months, and 6 months.
The clinical research will be conducted at the Auckland Myopia Clinic (New Zealand) and will follow a standard clinical routine for children with early myopia, the only difference being the randomizing of the MiSight and Abiliti contact lenses between the two eyes of the participants.
Interested in participating?
Request Info7 year–11 year
All sexes
Interventional
Phase 3
Auckland, 1052, New Zealand
Location status: Recruiting
o Spherical refractive error between -1.00D and -4.50D
o Astigmatism of ≤1.00D
o No history of orthokeratology or atropine use
o No ocular diseases or surgical history
2.2 Sample Size A similar study, of soft contact lenses with novel ring focus for controlling myopia progression, based their sample size on treatment efficacy of >0.08 mm (standard deviation [SD]: 0.10) in axial elongation from baseline and >0.20 D (SD: 0.32) in change of spherical equivalent cycloplegic autorefraction (SECAR) from baseline at 26 weeks. Controlling the 2-sided type I error rate at the 0.05 level, the researchers found that sample size of 40 subjects per group would yield >80% power for detecting treatment efficacy.
To estimate the sample size for the present study, a priori power analysis was performed using the program G∗Power (version 3.1.9.7). For a 95% confidence interval (Z = 1.96) and a study power of 80%, and controlling the 2-sided type I error rate at the 0.05 level, the estimated sample size is 53 pairs of eyes (53 subjects), as each participant contributes both eyes to the study. Providing for a 20% dropout rate, the recruitment target becomes 66 participants.
Each participant will wear:
o Children Dry Eye Questionnaire (CDEQ) responses
o Non-invasive Tear break-up time (NIBUT) using MYAH's dry eye function
o Ocular Protection Index (OPI) calculation using MYAH
o CDEQ responses
A structured questionnaire will be administered at baseline and at 6 months to assess parents' expectations and perceptions of the contact lenses as a myopia treatment. Topics covered include:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
o No ocular diseases or surgical history
Myopia Control Contact Lens
Myopia Control Contact Lens
Time frame: Baseline, 2 weeks, 3 months, 6 months
The dioptric refractive error as determined by retinoscopy following cycloplegic refraction
Time frame: Baseline, 2 weeks, 3 months, 6 months
Ocular biometry measured with Myah biometer
Time frame: Baseline, 2 weeks, 3 months, 6 months
Total score derived from the Children Dry Eye Questionnaire (CDEQ)
Time frame: Baseline, 2 weeks, 3 months, 6 months
Non-invasive Tear break-up time (NIBUT) using MYAH's objective dry eye function - time after a blink (in seconds) for the first break in the tear film to be detected
Time frame: Baseline, 2 weeks, 3 months, 6 months
Non-invasive breakup time secondary outcome measure divided by the average blink interval (number of blinks observed in a 60s period)
Time frame: Baseline, 2 weeks, 3 months, 6 months
Number of punctate spots observed on the cornea following instillation of fluorescein and illumination with a blue light source
Time frame: Baseline, 2 weeks, 3 months, 6 months
Number of puntate spots observed over the bulbar conjunctiva following instillation of lissamine green dye
Contact information is provided by the study sponsor or research team.
James S Wolffsohn, BSc PhD DSc
CONTACT
Vivienne Wang, BSc
CONTACT
Aston University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07698977
Eye Diseases, Myopia
Budapest, Hungary
View Trial DetailsNCT07229365
Eye Diseases, Juvenile Myopia
Bloomington, Indiana, United States
View Trial DetailsNCT07229352
Eye Diseases, Juvenile Myopia
Glendale, Arizona, United States
View Trial DetailsNCT07462897
Myopia Progression
Paris, France
View Trial Details